Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07389512
Recruiting
Pharmaceutical Management in Targeted Radioligand Therapy
Not applicable · France · 3 sites
Registry update: 5 Feb 2026
NCT06389565
Recruiting
Change My Story Task Shifted Mental Health Intervention
Not applicable · Nigeria · 1 site
Registry update: 6 Jul 2026
NCT06986590
Recruiting
Addressing Hypertension Care in Africa Program
Not applicable · Ghana, Nigeria, United States · 17 sites
Registry update: 14 Jan 2026
NCT07301255
Recruiting
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Phase 2 · United States · 20 sites
Registry update: 24 Sept 2026
NCT06898970
Recruiting
Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma
Phase 2 · United States · 1 site
Registry update: 1 Sept 2026
NCT07398391
Recruiting
Blood Pressure Care for Advancing Real-World Evidence (BPCARE)
Not applicable · United States · 2 sites
Registry update: 9 Feb 2026
NCT07358078
Recruiting
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Not applicable · Germany, Japan, United States · 27 sites
Registry update: 9 Oct 2026
NCT07284459
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Phase 2 · Argentina, Austria, Australia, Belgium, Canada, Chile, Germany, Denmark, Spain, France, United Kingdom, Greece, Israel, Italy, South Korea, Netherlands, New Zealand, Peru, Poland, Portugal, Serbia, Taiwan · 142 sites
Registry update: 5 Nov 2026
NCT07741305
Recruiting
Comparison of Three-dimensional and Two-dimensional Left Ventricle Strain With Speckle-tracking Echocardiography in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
Not applicable · Italy · 5 sites
Registry update: 19 Aug 2026
NCT07397624
Recruiting
Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer
Not applicable · Italy · 2 sites
Registry update: 12 Feb 2026
2024-519337-35-00
Recruiting
Exploring Eptinezumab: Unveiling Peripheral and Central Mechanisms of Action and Searching for Biomarkers of Patient Response (EUPHORIA Study)
Phase 4 · Italy · 1 site
Registry update: 10 Feb 2026
NCT07407725
Recruiting
Clinical Outcome Assessment for AT & BCI
Not applicable · United States · 1 site
Registry update: 6 Nov 2026
NCT07219576
Recruiting
Retifanlimab and Ruxolitinib In Solid Malignancies
Phase 1/2 · United States · 1 site
Registry update: 13 Jan 2026
NCT07158775
Recruiting
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
Phase 1/2 · United States · 1 site
Registry update: 23 Jan 2026
NCT07347860
Recruiting
Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis
Early phase 1 · China · 1 site
Registry update: 16 Jan 2026
NCT07388602
Recruiting
A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)
Phase 3 · China · 1 site
Registry update: 5 Feb 2026
NCT07253285
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Phase 3 · Austria, Australia, Belgium, Bulgaria, China, Colombia, Denmark, Spain, United Kingdom, Croatia, Hungary, Israel, India, Italy, Mexico, Malaysia, Netherlands, Poland, Portugal, Romania, Serbia, Sweden, Slovakia, Thailand, Taiwan, United States · 116 sites
Registry update: 30 Sept 2026
NCT06904261
Recruiting
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
Phase 3 · Belgium, Germany, Spain, United Kingdom, Japan, United States · 12 sites
Registry update: 22 Oct 2026
NCT07341711
Recruiting
Long-term Adaptations of Skeletal Muscle After Hybrid Training
Not applicable · Greece · 1 site
Registry update: 12 Jun 2026
NCT07322159
Recruiting
IASO206 in Patients With Relapsed/Refractory Multiple Myeloma
Early phase 1 · China · 1 site
Registry update: 9 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.